Lyell Immunopharma LYEL Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline NewAmsterdam Pharma NAMS Q1 2026 Earnings EPS Beat Reflects Cost Management Amid PreRevenue Phase MIND Technology Q1 2026 Earnings EPS Misses Estimates Amid Strategic Shifts enCore Energy Corp EU Q1 2026 Earnings Surprise Profit Driven by Strong Uranium Sales OCUL Q1 2026 Earnings WiderthanExpected Loss but Stock Gains on Pipeline Progress UAN Q1 2026 Earnings Strong EPS of 472 Driven by Favorable Nitrogen Market Units Dip Slightly